| Dr Mehrdad Farahmand, MD | |
|
1200 E Columbia Ave, Colville, WA 99114-3354 | |
| (509) 684-3701 | |
| (509) 684-5817 |
| Full Name | Dr Mehrdad Farahmand |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 32 Years |
| Location | 1200 E Columbia Ave, Colville, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629066733 | NPI | - | NPPES |
| 0151118 | Other | L AND I | |
| AB32999 | Other | WA | MEDICARE GROUP |
| 8234999 | Medicaid | WA | |
| 8924170 | Other | L AND I CRIME VICTIMS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD00036564 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Mount Carmel Hospital | Colville, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Washington | 0345139929 | 687 |
News Archive
A state advisory group on Thursday recommended legislative changes to bolster oversight of coronary stent placements amid widespread concerns about unnecessary medical procedures, but it stopped short of proposing that state law regulate physician reviews in hospitals.
The U.S. Patent and Trademark Office has approved Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, intellectual property protection to patent application 11/223,945 - a live, attenuated Listeria vaccine that secretes novel fragments of the tumor antigen HER2/neu (human epidermal growth factor receptor 2), when using the company's proprietary listeriolysin O (LLO) fusion platform technology.
febit today announced that an updated version of the company's Geniom Biochip containing 58 new discovered sequences in addition to all of the Homo sapiens microRNAs (miRNA) from miRBase version 14 is now available for cancer research. The 58 new miRNA sequences were found by deep sequencing in a miRNA discovery study performed on an Applied Biosystems SOLiD 3 sequencing system. All 58 miRNAs have been validated using the ABI TaqMan miRNA qRT-PCR assay and are now available for further studies using febit's microarray technology for miRNA-profiling.
The globalization of health care and the growth of "transplant tourism" (traveling abroad to purchase donor organs and undergo organ transplantation) have outpaced the implementation of internationally accepted ethical standards for procurement of organs for transplantation.
› Verified 8 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194099390 PECOS PAC ID: 0345139929 Enrollment ID: O20040311001453 |
News Archive
A state advisory group on Thursday recommended legislative changes to bolster oversight of coronary stent placements amid widespread concerns about unnecessary medical procedures, but it stopped short of proposing that state law regulate physician reviews in hospitals.
The U.S. Patent and Trademark Office has approved Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, intellectual property protection to patent application 11/223,945 - a live, attenuated Listeria vaccine that secretes novel fragments of the tumor antigen HER2/neu (human epidermal growth factor receptor 2), when using the company's proprietary listeriolysin O (LLO) fusion platform technology.
febit today announced that an updated version of the company's Geniom Biochip containing 58 new discovered sequences in addition to all of the Homo sapiens microRNAs (miRNA) from miRBase version 14 is now available for cancer research. The 58 new miRNA sequences were found by deep sequencing in a miRNA discovery study performed on an Applied Biosystems SOLiD 3 sequencing system. All 58 miRNAs have been validated using the ABI TaqMan miRNA qRT-PCR assay and are now available for further studies using febit's microarray technology for miRNA-profiling.
The globalization of health care and the growth of "transplant tourism" (traveling abroad to purchase donor organs and undergo organ transplantation) have outpaced the implementation of internationally accepted ethical standards for procurement of organs for transplantation.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mehrdad Farahmand, MD Po Box 421, Liberty Lake, WA 99019-0421 Ph: (866) 747-2455 | Dr Mehrdad Farahmand, MD 1200 E Columbia Ave, Colville, WA 99114-3354 Ph: (509) 684-3701 |
News Archive
A state advisory group on Thursday recommended legislative changes to bolster oversight of coronary stent placements amid widespread concerns about unnecessary medical procedures, but it stopped short of proposing that state law regulate physician reviews in hospitals.
The U.S. Patent and Trademark Office has approved Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, intellectual property protection to patent application 11/223,945 - a live, attenuated Listeria vaccine that secretes novel fragments of the tumor antigen HER2/neu (human epidermal growth factor receptor 2), when using the company's proprietary listeriolysin O (LLO) fusion platform technology.
febit today announced that an updated version of the company's Geniom Biochip containing 58 new discovered sequences in addition to all of the Homo sapiens microRNAs (miRNA) from miRBase version 14 is now available for cancer research. The 58 new miRNA sequences were found by deep sequencing in a miRNA discovery study performed on an Applied Biosystems SOLiD 3 sequencing system. All 58 miRNAs have been validated using the ABI TaqMan miRNA qRT-PCR assay and are now available for further studies using febit's microarray technology for miRNA-profiling.
The globalization of health care and the growth of "transplant tourism" (traveling abroad to purchase donor organs and undergo organ transplantation) have outpaced the implementation of internationally accepted ethical standards for procurement of organs for transplantation.
› Verified 8 days ago
L. Royce Larsen, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 E Columbia Ave, Colville, WA 99114 Phone: 509-684-3701 Fax: 509-684-5817 | |
Jess Morgan Schultz, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 E Columbia Ave, Colville, WA 99114 Phone: 509-384-3701 Fax: 509-684-5817 |